Neurology® Podcast

In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.

In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.

In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.

In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN's patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.

The October 2021 replay of past episodes showcases a selection of interviews focused on thunderclap headache. This episode features Dr. Tesha Monteith in conversation with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, as well as with headache experts Drs. Jonathan Smith, Dileep Yavagal, and Alexandra Cocores.

In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.

Dr. Alex Menze discusses the acute and chronic effects of a history of concussions with Dr. Nathan Churchill.

In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Eoin Flanagan about how MRI T-2 lesion evolution differs across central nervous system demyelinating disorders. In the second segment, Dr. Teshamae Monteith talks with Dr. Gabriela Carvalho about behavioral and neuronal responses to a virtual roller coaster ride in patients with migraine.

In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.